Effect of Extending the Duration of Prequit Treatment With Varenicline on Smoking Abstinence: A Randomized Clinical Trial

IMPORTANCE: Even with varenicline, the leading monotherapy for tobacco dependence, smoking abstinence rates remain low. Preliminary evidence suggests that extending the duration of varenicline treatment before quitting may increase abstinence. OBJECTIVE: To test the hypotheses that, compared with st...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawk, Larry W., Tiffany, Stephen T., Colder, Craig R., Ashare, Rebecca L., Wray, Jennifer M., Tyndale, Rachel F., Brandon, Thomas H., Mahoney, Martin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652761/
https://www.ncbi.nlm.nih.gov/pubmed/36367720
http://dx.doi.org/10.1001/jamanetworkopen.2022.41731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652761/
https://www.ncbi.nlm.nih.gov/pubmed/36367720
http://dx.doi.org/10.1001/jamanetworkopen.2022.41731

Ejemplares similares